{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:19:33Z","timestamp":1790399973560,"version":"4.1.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1124\/pr.117.013904","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T00:40:25Z","timestamp":1498005625000},"page":"298-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Conjugate Vaccine Immunotherapy for Substance Use Disorder"],"prefix":"10.1016","volume":"69","author":[{"given":"Paul T.","family":"Bremer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim D.","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pr.117.013904_bib1","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00213-015-3944-8","article-title":"In vivo potency and efficacy of the novel cathinone \u03b1-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats","volume":"232","author":"Aarde","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.117.013904_bib2","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00213-014-3819-4","article-title":"Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats","volume":"232","author":"Aarde","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.117.013904_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/jpet.109.152462","article-title":"Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a prodrug for the mediator 6-monoacetylmorphine in vivo","volume":"331","author":"Andersen","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.013904_bib4","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.142.7.2464","volume":"142","author":"Anderson","year":"1989","journal-title":"J Immunol"},{"key":"10.1124\/pr.117.013904_bib5","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib6","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/nm.2535","article-title":"A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design","volume":"17","author":"Avci","year":"2011","journal-title":"Nat Med"},{"key":"10.1124\/pr.117.013904_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/pr.117.013904_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0809s41","article-title":"Models of nociception: hot-plate, tail-flick, and formalin tests in rodents","author":"Bannon","year":"2007","journal-title":"Curr Protoc Neurosci"},{"key":"10.1124\/pr.117.013904_bib9","doi-asserted-by":"crossref","first-page":"28759","DOI":"10.1074\/jbc.273.44.28759","article-title":"New synthetic non-peptide ligands for classical major histocompatibility complex class I molecules","volume":"273","author":"Bianco","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.117.013904_bib10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/252708a0","article-title":"Changes in heroin self-administration by a rhesus monkey after morphine immunization","volume":"252","author":"Bonese","year":"1974","journal-title":"Nature"},{"key":"10.1124\/pr.117.013904_bib11","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1073\/pnas.151105198","article-title":"Trace amines: identification of a family of mammalian G protein-coupled receptors","volume":"98","author":"Borowsky","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.013904_bib12","doi-asserted-by":"crossref","first-page":"10776","DOI":"10.1021\/jm301262z","article-title":"Investigating the effects of a hydrolytically stable hapten and a Th1 adjuvant on heroin vaccine performance","volume":"55","author":"Bremer","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.013904_bib13","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/anie.201511654","article-title":"Combatting synthetic designer opioids: a conjugate vaccine ablates lethal doses of fentanyl class drugs","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pr.117.013904_bib145","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a clinically-viable heroin vaccine","author":"Bremer","year":"2017","journal-title":"J Amer Chem Soc"},{"key":"10.1124\/pr.117.013904_bib14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/mp400631w","article-title":"Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy","volume":"11","author":"Bremer","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.117.013904_bib15","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1200\/JCO.2010.28.9793","article-title":"In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I\/II study","volume":"28","author":"Brody","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1124\/pr.117.013904_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/364033a0","article-title":"Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1","volume":"364","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"10.1124\/pr.117.013904_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1567-5769(00)00019-9","article-title":"Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats","volume":"1","author":"Byrnes-Blake","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pr.117.013904_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(03)01313-X","article-title":"Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats","volume":"461","author":"Byrnes-Blake","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.117.013904_bib19","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1021\/mp400214w","article-title":"Probing the effects of hapten stability on cocaine vaccine immunogenicity","volume":"10","author":"Cai","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.117.013904_bib20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/378727a0","article-title":"Suppression of psychoactive effects of cocaine by active immunization","volume":"378","author":"Carrera","year":"1995","journal-title":"Nature"},{"key":"10.1124\/pr.117.013904_bib21","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1073\/pnas.98.4.1988","article-title":"A second-generation vaccine protects against the psychoactive effects of cocaine","volume":"98","author":"Carrera","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.013904_bib22","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1021\/jm2004943","article-title":"Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines","volume":"54","author":"Carroll","year":"2011","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.013904_bib23","first-page":"703","article-title":"Acetyl fentanyl overdose fatalities: Rhode Island, March-May 2013","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1124\/pr.117.013904_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vaccine.2012.10.069","article-title":"High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants","volume":"31","author":"Chen","year":"2012","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/330381a0","article-title":"Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein","volume":"330","author":"Clarke","year":"1987","journal-title":"Nature"},{"key":"10.1124\/pr.117.013904_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/bc500016k","article-title":"Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuse","volume":"25","author":"Collins","year":"2014","journal-title":"Bioconjug Chem"},{"key":"10.1124\/pr.117.013904_bib27","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/acs.jmedchem.6b00084","article-title":"Methamphetamine vaccines: improvement through hapten design","volume":"59","author":"Collins","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.013904_bib28","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1039\/C4CC00682H","article-title":"Lipid tucaresol as an adjuvant for methamphetamine vaccine development","volume":"50","author":"Collins","year":"2014","journal-title":"Chem Commun (Camb)"},{"key":"10.1124\/pr.117.013904_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10875-004-6244-3","article-title":"CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I\/II study","volume":"24","author":"Cooper","year":"2004","journal-title":"J Clin Immunol"},{"key":"10.1124\/pr.117.013904_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082557","article-title":"Immunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to vaccine formulation and administration conditions","volume":"8","author":"Cornish","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pr.117.013904_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002547","article-title":"A vaccine against nicotine for smoking cessation: a randomized controlled trial","volume":"3","author":"Cornuz","year":"2008","journal-title":"PLoS One"},{"key":"10.1124\/pr.117.013904_bib32","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.vaccine.2009.12.051","article-title":"Nicotine hapten structure, antibody selectivity and effect relationships: results from a nicotine vaccine screening procedure","volume":"28","author":"de Villiers","year":"2010","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib33","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1016\/j.vaccine.2013.10.051","article-title":"Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum","volume":"31","author":"de Villiers","year":"2013","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000063628","article-title":"Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell","volume":"69","author":"de Villiers","year":"2002","journal-title":"Respiration"},{"key":"10.1124\/pr.117.013904_bib35","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/npp.2015.64","article-title":"Effects of the nanoparticle-based vaccine, SEL-068, on nicotine discrimination in squirrel monkeys","volume":"40","author":"Desai","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.117.013904_bib36","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.013904_bib37","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.vaccine.2009.02.105","article-title":"Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines","volume":"27","author":"Duryee","year":"2009","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib38","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminum adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"10.1124\/pr.117.013904_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pbb.2016.09.008","article-title":"Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques","volume":"150-151","author":"Evans","year":"2016","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.117.013904_bib40","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm1096-1129","article-title":"Efficacy of a therapeutic cocaine vaccine in rodent models","volume":"2","author":"Fox","year":"1996","journal-title":"Nat Med"},{"key":"10.1124\/pr.117.013904_bib41","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/eji.200838549","article-title":"The Nlrp3 inflammasome is critical for aluminum hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity","volume":"38","author":"Franchi","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1124\/pr.117.013904_bib42","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJMp1615145","article-title":"Addressing the fentanyl threat to public health","volume":"376","author":"Frank","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.117.013904_bib43","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.vaccine.2014.02.024","article-title":"Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates","volume":"32","author":"Fraser","year":"2014","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0022-1759(85)90044-4","article-title":"Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay","volume":"77","author":"Friguet","year":"1985","journal-title":"J Immunol Methods"},{"key":"10.1124\/pr.117.013904_bib45","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1126\/science.1135299","article-title":"Adjuvant-enhanced antibody responses in the absence of Toll-like receptor signaling","volume":"314","author":"Gavin","year":"2006","journal-title":"Science"},{"key":"10.1124\/pr.117.013904_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/path.1700340214","article-title":"Rate of disappearance of diphtheria toxoid injected into rabbits and guinea pigs: toxoid precipitated with alum","volume":"34","author":"Glenny","year":"1931","journal-title":"J Pathol Bacteriol"},{"key":"10.1124\/pr.117.013904_bib47","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1021\/acschemneuro.6b00389","article-title":"Influencing antibody-mediated attenuation of methamphetamine CNS distribution through vaccine linker design","volume":"8","author":"Gooyit","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pr.117.013904_bib48","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/ajad.12307","article-title":"Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine","volume":"24","author":"Haile","year":"2015","journal-title":"Am J Addict"},{"key":"10.1124\/pr.117.013904_bib49","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.vaccine.2008.11.078","article-title":"Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response","volume":"27","author":"Hansen","year":"2009","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib50","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1016\/j.vaccine.2007.06.049","article-title":"Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response","volume":"25","author":"Hansen","year":"2007","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib51","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0028-3908(73)90120-2","article-title":"Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues","volume":"12","author":"Harris","year":"1973","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.013904_bib52","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.164.2.944","article-title":"Mechanism and function of a newly identified CpG DNA motif in human primary B cells","volume":"164","author":"Hartmann","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/pr.117.013904_bib53","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4049\/jimmunol.164.3.1617","article-title":"Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo","volume":"164","author":"Hartmann","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/pr.117.013904_bib54","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.2010.317","article-title":"Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic","volume":"89","author":"Hatsukami","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.117.013904_bib55","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clpt.2005.08.007","article-title":"Safety and immunogenicity of a nicotine conjugate vaccine in current smokers","volume":"78","author":"Hatsukami","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.117.013904_bib56","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/mt.2010.280","article-title":"Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs","volume":"19","author":"Hicks","year":"2011","journal-title":"Mol Ther"},{"key":"10.1124\/pr.117.013904_bib57","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/humc.2013.231","article-title":"Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine","volume":"25","author":"Hicks","year":"2014","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.1124\/pr.117.013904_bib58","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0192-0561(00)00042-4","article-title":"Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain","volume":"22","author":"Hieda","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"10.1124\/pr.117.013904_bib59","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0022-3565(24)37155-1","article-title":"Active immunization alters the plasma nicotine concentration in rats","volume":"283","author":"Hieda","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.013904_bib60","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s002130050930","article-title":"Immunization of rats reduces nicotine distribution to brain","volume":"143","author":"Hieda","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.117.013904_bib61","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4049\/jimmunol.114.4.1363","article-title":"Delayed clearance of morphine from the circulation of rabbits immunized with morphine-6-hemisuccinate bovine serum albumin","volume":"114","author":"Hill","year":"1975","journal-title":"J Immunol"},{"key":"10.1124\/pr.117.013904_bib62","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/add.12573","article-title":"Efficacy of the nicotine vaccine 3\u2032-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial","volume":"109","author":"Hoogsteder","year":"2014","journal-title":"Addiction"},{"key":"10.1124\/pr.117.013904_bib63","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1021\/jo001442w","article-title":"An immunotherapeutic program for the treatment of nicotine addiction: hapten design and synthesis","volume":"66","author":"Isomura","year":"2001","journal-title":"J Org Chem"},{"key":"10.1124\/pr.117.013904_bib64","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1021\/acs.jmedchem.5b01676","article-title":"Investigations of enantiopure nicotine haptens using an adjuvanting carrier in anti-nicotine vaccine development","volume":"59","author":"Jacob","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.013904_bib65","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/acs.bioconjchem.5b00085","article-title":"Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers","volume":"26","author":"Jalah","year":"2015","journal-title":"Bioconjug Chem"},{"key":"10.1124\/pr.117.013904_bib66","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.bcp.2005.02.007","article-title":"Reduced nicotine distribution from mother to fetal brain in rats vaccinated against nicotine: time course and influence of nicotine dosing regimen","volume":"69","author":"Keyler","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.117.013904_bib67","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.intimp.2008.07.001","article-title":"Enhanced immunogenicity of a bivalent nicotine vaccine","volume":"8","author":"Keyler","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pr.117.013904_bib68","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/jpet.102.046805","article-title":"Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats","volume":"305","author":"Keyler","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.013904_bib69","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1021\/acs.molpharmaceut.6b00682","article-title":"Cocaine vaccine development: evaluation of carrier and adjuvant combinations that activate multiple Toll-like receptors","volume":"13","author":"Kimishima","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.117.013904_bib70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/acschembio.6b00977","article-title":"An advance in prescription opioid vaccines: overdose mortality reduction and extraordinary alteration of drug half-life","volume":"12","author":"Kimishima","year":"2017","journal-title":"ACS Chem Biol"},{"key":"10.1124\/pr.117.013904_bib71","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.4049\/jimmunol.181.6.3755","article-title":"Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome","volume":"181","author":"Kool","year":"2008","journal-title":"J Immunol"},{"key":"10.1124\/pr.117.013904_bib72","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.20071087","article-title":"Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells","volume":"205","author":"Kool","year":"2008","journal-title":"J Exp Med"},{"key":"10.1124\/pr.117.013904_bib73","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2014.04.003","article-title":"Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial","volume":"140","author":"Kosten","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/pr.117.013904_bib74","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0264-410X(01)00425-X","article-title":"Human therapeutic cocaine vaccine: safety and immunogenicity","volume":"20","author":"Kosten","year":"2002","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib75","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U","article-title":"Identification of CpG oligonucleotide sequences with high induction of IFN-alpha\/beta in plasmacytoid dendritic cells","volume":"31","author":"Krug","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1124\/pr.117.013904_bib76","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00213-005-0027-2","article-title":"Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats","volume":"184","author":"LeSage","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.117.013904_bib77","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.1039\/C4OB01053A","article-title":"Synthesis and immunological effects of heroin vaccines","volume":"12","author":"Li","year":"2014","journal-title":"Org Biomol Chem"},{"key":"10.1124\/pr.117.013904_bib78","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/eji.200425749","article-title":"High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins","volume":"35","author":"Liu","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1124\/pr.117.013904_bib79","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2004.05.028","article-title":"High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity","volume":"23","author":"Liu","year":"2004","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib80","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bmcl.2012.12.048","article-title":"Enhancing nicotine vaccine immunogenicity with liposomes","volume":"23","author":"Lockner","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pr.117.013904_bib81","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1021\/jm501625j","article-title":"A conjugate vaccine using enantiopure hapten imparts superior nicotine-binding capacity","volume":"58","author":"Lockner","year":"2015","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.013904_bib82","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1038\/npp.2013.114","article-title":"Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter","volume":"38","author":"Maoz","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.117.013904_bib83","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nm.2403","article-title":"DNA released from dying host cells mediates aluminum adjuvant activity","volume":"17","author":"Marichal","year":"2011","journal-title":"Nat Med"},{"key":"10.1124\/pr.117.013904_bib84","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2005.04.032","article-title":"Vaccine pharmacotherapy for the treatment of cocaine dependence","volume":"58","author":"Martell","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.117.013904_bib85","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial","volume":"66","author":"Martell","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.117.013904_bib86","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1124\/pr.117.013904_bib87","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/j.vaccine.2013.04.027","article-title":"Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs","volume":"31","author":"Matyas","year":"2013","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib88","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.vaccine.2014.01.028","article-title":"Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine","volume":"32","author":"Matyas","year":"2014","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib89","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.intimp.2013.03.021","article-title":"Enhancing immunogenicity of a 3'aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates","volume":"16","author":"McCluskie","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pr.117.013904_bib90","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.intimp.2015.09.012","article-title":"Anti-nicotine vaccines: comparison of adjuvanted CRM197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates","volume":"29","author":"McCluskie","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pr.117.013904_bib91","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.intimp.2015.02.030","article-title":"Molecular attributes of conjugate antigen influence function of antibodies induced by anti-nicotine vaccine in mice and non-human primates","volume":"25","author":"McCluskie","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pr.117.013904_bib92","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1124\/jpet.103.061762","article-title":"Effects of murine-derived anti-methamphetamine monoclonal antibodies on (+)-methamphetamine self-administration in the rat","volume":"309","author":"McMillan","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.013904_bib93","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1021\/ja034805t","article-title":"A new strategy for improved nicotine vaccines using conformationally constrained haptens","volume":"125","author":"Meijler","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.117.013904_bib94","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2015.06.014","article-title":"Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats","volume":"153","author":"Miller","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/pr.117.013904_bib95","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2012.09.010","article-title":"A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats","volume":"73","author":"Miller","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.117.013904_bib96","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.vaccine.2004.07.050","article-title":"Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro","volume":"23","author":"Morefield","year":"2005","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib97","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1016\/j.vaccine.2012.08.064","article-title":"Probing the protective effects of a conformationally constrained nicotine vaccine","volume":"30","author":"Moreno","year":"2012","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib98","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1021\/mp900213u","article-title":"A critical evaluation of a nicotine vaccine within a self-administration behavioral model","volume":"7","author":"Moreno","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.117.013904_bib99","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1021\/ja108807j","article-title":"Impact of distinct chemical structures for the development of a methamphetamine vaccine","volume":"133","author":"Moreno","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.117.013904_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002940","article-title":"Phase 1 trial of AMA1-C1\/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria","volume":"3","author":"Mullen","year":"2008","journal-title":"PLoS One"},{"key":"10.1124\/pr.117.013904_bib101","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0076-6879(83)92046-3","article-title":"Determination of affinity and specificity of anti-hapten antibodies by competitive radioimmunoassay","volume":"92","author":"M\u00fcller","year":"1983","journal-title":"Methods Enzymol"},{"key":"10.1124\/pr.117.013904_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2016.12.005","article-title":"Active vaccination attenuates the psychostimulant effects of \u03b1-PVP and MDPV in rats","volume":"116","author":"Nguyen","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.013904_bib103","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.drugalcdep.2017.03.005","article-title":"Effective active vaccination against methamphetamine in female rats","volume":"175","author":"Nguyen","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/pr.117.013904_bib104","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1016\/j.vaccine.2010.02.085","article-title":"Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response","volume":"28","author":"Noe","year":"2010","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.106.111781","article-title":"A chimeric human\/murine anticocaine monoclonal antibody inhibits the distribution of cocaine to the brain in mice","volume":"320","author":"Norman","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.013904_bib106","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0091-3057(99)00206-3","article-title":"A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats","volume":"65","author":"Pentel","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.117.013904_bib107","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/jpet.106.117150","article-title":"Using hapten design to discover therapeutic monoclonal antibodies for treating methamphetamine abuse","volume":"322","author":"Peterson","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.013904_bib108","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl","key":"10.1124\/pr.117.013904_bib109","doi-asserted-by":"crossref","first-page":"75.11","DOI":"10.4049\/jimmunol.188.Supp.75.11","article-title":"Development and preclinical evaluation of SEL-068, a novel targeted synthetic vaccine particle (tSVP (TM)) for smoking cessation and relapse prevention that generates high titers of antibodies against nicotine","volume":"188","author":"Pittet","year":"2012","journal-title":"J Immunol"},{"key":"10.1124\/pr.117.013904_bib110","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bcp.2011.11.004","article-title":"Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities","volume":"83","author":"Pravetoni","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.117.013904_bib111","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/jpet.111.189506","article-title":"An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia","volume":"341","author":"Pravetoni","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.013904_bib112","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/jm3013745","article-title":"Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens","volume":"56","author":"Pravetoni","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.013904_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101807","article-title":"Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pr.117.013904_bib114","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1016\/j.vaccine.2012.04.101","article-title":"Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats","volume":"30","author":"Pravetoni","year":"2012","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096547","article-title":"Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pr.117.013904_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076557","article-title":"Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in mice","volume":"8","author":"Pryde","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pr.117.013904_bib117","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1021\/jm050442r","article-title":"Delta9-tetrahydrocannabinol immunochemical studies: haptens, monoclonal antibodies, and a convenient synthesis of radiolabeled delta9-tetrahydrocannabinol","volume":"48","author":"Qi","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.013904_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115696","article-title":"Pharmacokinetic correlates of the effects of a heroin vaccine on heroin self-administration in rats","volume":"9","author":"Raleigh","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pr.117.013904_bib119","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.112.201194","article-title":"Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats","volume":"344","author":"Raleigh","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.013904_bib120","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/cbdd.12326","article-title":"Hapten optimization for cocaine vaccine with improved cocaine recognition","volume":"84","author":"Ramakrishnan","year":"2014","journal-title":"Chem Biol Drug Des"},{"key":"10.1124\/pr.117.013904_bib121","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters are related to self-administration of cocaine","volume":"237","author":"Ritz","year":"1987","journal-title":"Science"},{"key":"10.1124\/pr.117.013904_bib122","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0022-3565(24)35230-9","article-title":"Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat","volume":"291","author":"Rivi\u00e8re","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.013904_bib123","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.vaccine.2006.09.039","article-title":"Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants","volume":"25","author":"Romero M\u00e9ndez","year":"2007","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib124","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/353622a0","article-title":"Sequence analysis of peptides bound to MHC class II molecules","volume":"353","author":"Rudensky","year":"1991","journal-title":"Nature"},{"key":"10.1124\/pr.117.013904_bib125","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1016\/j.vaccine.2013.07.038","article-title":"Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food","volume":"31","author":"R\u00fcedi-Bettschen","year":"2013","journal-title":"Vaccine"},{"key":"10.1124\/pr.117.013904_bib126","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1073\/pnas.1219159110","article-title":"Dynamic vaccine blocks relapse to compulsive intake of heroin","volume":"110","author":"Schlosburg","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.013904_bib127","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0006-2952(01)00689-X","article-title":"mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine","volume":"62","author":"Selley","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.117.013904_bib128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drugalcdep.2012.09.007","article-title":"A vaccine against methamphetamine attenuates its behavioral effects in mice","volume":"129","author":"Shen","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/pr.117.013904_bib129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/653112","article-title":"Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a Toll-like receptor 9 agonist adjuvant: a randomized, controlled trial","volume":"51","author":"S\u00f8gaard","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1124\/pr.117.013904_bib130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0022-3565(25)28956-X","article-title":"Quantitative determination of morphine in serum by radioimmunoassay","volume":"178","author":"Spector","year":"1971","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.013904_bib131","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0031-6997(25)06605-0","article-title":"Antibodies to morphine, barbiturates, and serotonin","volume":"25","author":"Spector","year":"1973","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.117.013904_bib132","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.168.3937.1347","article-title":"Morphine: radioimmunoassay","volume":"168","author":"Spector","year":"1970","journal-title":"Science"},{"key":"10.1124\/pr.117.013904_bib133","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.intimp.2016.03.028","article-title":"Optimization of a methamphetamine conjugate vaccine for antibody production in mice","volume":"35","author":"Stevens","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pr.117.013904_bib134","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.annemergmed.2014.07.017","article-title":"The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl \u201cdisguised\u201d as other opioids","volume":"64","author":"Stogner","year":"2014","journal-title":"Ann Emerg Med"},{"key":"10.1124\/pr.117.013904_bib135","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.013904_bib136","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00216-015-9223-z","article-title":"A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse","volume":"408","author":"Torres","year":"2016","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pr.117.013904_bib137","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.1073\/pnas.0703395104","article-title":"Vaccination with NY-ESO-1 protein and CpG in montanide induces integrated antibody\/Th1 responses and CD8 T cells through cross-priming","volume":"104","author":"Valmori","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.013904_bib138","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0022-3565(25)29131-5","article-title":"Specificities of antibodies to morphine","volume":"180","author":"Van Vunakis","year":"1972","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.013904_bib139","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/14622200701704921","article-title":"The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1\/2 trial","volume":"10","author":"Wagena","year":"2008","journal-title":"Nicotine Tob Res"},{"key":"10.1124\/pr.117.013904_bib140","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2010-2014","volume":"65","author":"Warner","year":"2016","journal-title":"Natl Vital Stat Rep"},{"key":"10.1124\/pr.117.013904_bib141","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","article-title":"Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)","volume":"19","author":"Watterson","year":"2014","journal-title":"Addict Biol"},{"key":"10.1124\/pr.117.013904_bib146","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/npp.2011.200","article-title":"Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects","volume":"37","author":"Wee","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.117.013904_bib142","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/1074-5521(95)90221-X","article-title":"A tricyclic ring system replaces the variable regions of peptides presented by three alleles of human MHC class I molecules","volume":"2","author":"Weiss","year":"1995","journal-title":"Chem Biol"},{"key":"10.1124\/pr.117.013904_bib143","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.109.153775","article-title":"A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain","volume":"330","author":"Xie","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.013904_bib144","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1016\/j.vaccine.2012.03.021","article-title":"Immunization with high epitope density of M2e derived from 2009 pandemic H1N1 elicits protective immunity in mice","volume":"30","author":"Zhou","year":"2012","journal-title":"Vaccine"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724012286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724012286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pr.117.013904","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T10:55:40Z","timestamp":1739876140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724012286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":146,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0031699724012286"],"URL":"https:\/\/doi.org\/10.1124\/pr.117.013904","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conjugate Vaccine Immunotherapy for Substance Use Disorder","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pr.117.013904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}